| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |